Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Get Free Report) was upgraded by investment analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued on Monday,Zacks.com reports.
A number of other research analysts have also weighed in on the stock. Jefferies Financial Group raised shares of Fresenius Medical Care AG & Co. KGaA from a “strong sell” rating to a “moderate sell” rating in a research note on Friday, May 8th. Weiss Ratings lowered Fresenius Medical Care AG & Co. KGaA from a “hold (c+)” rating to a “hold (c)” rating in a research report on Thursday, May 7th. Morgan Stanley reaffirmed an “underweight” rating on shares of Fresenius Medical Care AG & Co. KGaA in a report on Wednesday, May 6th. Wall Street Zen lowered Fresenius Medical Care AG & Co. KGaA from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Finally, Citigroup restated a “neutral” rating on shares of Fresenius Medical Care AG & Co. KGaA in a report on Friday, April 24th. Five analysts have rated the stock with a Hold rating and four have assigned a Sell rating to the company. According to MarketBeat, the company has an average rating of “Reduce” and an average target price of $28.00.
Fresenius Medical Care AG & Co. KGaA Trading Up 2.5%
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Get Free Report) last posted its quarterly earnings results on Tuesday, March 31st. The company reported $1.05 earnings per share for the quarter. The firm had revenue of $5.34 billion for the quarter. Fresenius Medical Care AG & Co. KGaA had a net margin of 4.88% and a return on equity of 8.90%. Research analysts forecast that Fresenius Medical Care AG & Co. KGaA will post 2.24 earnings per share for the current fiscal year.
Institutional Trading of Fresenius Medical Care AG & Co. KGaA
Several institutional investors have recently added to or reduced their stakes in the stock. AQR Capital Management LLC lifted its stake in Fresenius Medical Care AG & Co. KGaA by 14.2% during the 1st quarter. AQR Capital Management LLC now owns 14,297 shares of the company’s stock worth $356,000 after acquiring an additional 1,777 shares in the last quarter. JPMorgan Chase & Co. grew its position in Fresenius Medical Care AG & Co. KGaA by 160.3% in the 2nd quarter. JPMorgan Chase & Co. now owns 37,610 shares of the company’s stock valued at $1,075,000 after acquiring an additional 23,163 shares in the last quarter. American Century Companies Inc. increased its stake in Fresenius Medical Care AG & Co. KGaA by 21.3% during the second quarter. American Century Companies Inc. now owns 29,173 shares of the company’s stock worth $833,000 after purchasing an additional 5,127 shares during the period. Russell Investments Group Ltd. lifted its position in shares of Fresenius Medical Care AG & Co. KGaA by 21.3% during the second quarter. Russell Investments Group Ltd. now owns 5,096 shares of the company’s stock worth $146,000 after purchasing an additional 896 shares in the last quarter. Finally, EverSource Wealth Advisors LLC boosted its stake in shares of Fresenius Medical Care AG & Co. KGaA by 141.8% in the second quarter. EverSource Wealth Advisors LLC now owns 2,906 shares of the company’s stock valued at $83,000 after purchasing an additional 1,704 shares during the period. Institutional investors and hedge funds own 8.37% of the company’s stock.
Fresenius Medical Care AG & Co. KGaA Company Profile
Fresenius Medical Care AG & Co KGaA is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.
In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines.
Featured Articles
- Five stocks we like better than Fresenius Medical Care AG & Co. KGaA
- Apple and Broadcom Forge a Decade-Long Silicon Fortress
- SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade
- The AI Chip Sell-Off Looks Scary, But the Real Story May Be Liquidity
- Palantir’s CEO Just Called Out OpenAI and Anthropic
Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
